top of page
Stack of Magazines

Other publications of interest

  • Baarsma, M. E., F. R. van de Schoor, S. A. Gauw, H. D. Vrijmoeth, J. Ursinus, N. Goudriaan, C. D. Popa, H. J. Ter Hofstede, M. M. Leeflang, K. Kremer, C. C. van den Wijngaard, B. J. Kullberg, L. A. Joosten, and J. W. Hovius. "Diagnostic Parameters of Cellular Tests for Lyme Borreliosis in Europe (Victory Study): A Case-Control Study." Lancet Infect Dis 22, no. 9 (Sep 2022): 1388-96. doi: 10.1016/S1473-3099(22)00205-5.

  • Breukers EMC, Raijmakers RPH, Nieuwkerk PT, Bleijenberg G, van der Meer JWM, Bleeker-Rovers CP, Keijmel SP, Knoop H. Mediation analysis shows that a decline in self-efficacy mediates the increase in fatigue severity following an initial positive response to cognitive behavioural therapy in Q fever fatigue syndrome. J Psychosom Res. 2019 Dec;127:109841. doi: 10.1016/j.jpsychores.2019.109841. 

  • Garratt AM, Ghanima W, Einvik G, Stavem K. Quality of life after COVID-19 without hospitalisation: Good overall, but reduced in some dimensions. J Infect. 2021 May;82(5):186-230. doi: 10.1016/j.jinf.2021.01.002. 

  • Huiberts AJ, Vermeeren YM, van Bemmel T, Wieberdink RG, van Jaarsveld CHM, Zomer TP. Coping strategies and quality of life in patients with chronic symptoms visiting a Lyme Center in a Dutch teaching hospital. Qual Life Res. 2022 Aug;31(8):2423-2434. doi: 10.1007/s11136-022-03094-2. 

  • Ingul CB, Edvardsen A, Follestad T, Trebinjac D, Ankerstjerne OAW, Brønstad E, Rasch-Halvorsen Ø, Aarli B, Dalen H, Nes BM, Lerum TV, Einvik G, Stavem K, Skjørten I. Changes in cardiopulmonary exercise capacity and limitations 3-12 months after COVID-19. Eur Respir J. 2023 Feb 2;61(2):2200745. doi: 10.1183/13993003.00745-2022. 

  • Jason LA, Conroy KE, Furst J, Vasan K, Katz BZ. Pre-illness data reveals differences in multiple metabolites and metabolic pathways in those who do and do not recover from infectious mononucleosis. Mol Omics. 2022 Aug 15;18(7):662-665. doi: 10.1039/d2mo00124a.

  • Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. 2009 Jul;124(1):189-93. doi: 10.1542/peds.2008-1879. 

  • Katz BZ, Reuter C, Lupovitch Y, Gleason K, McClellan D, Cotler J, Jason LA. A Validated Scale for Assessing the Severity of Acute Infectious Mononucleosis. J Pediatr. 2019 Jun;209:130-133. doi: 10.1016/j.jpeds.2019.01.035.

  • Keijmel SP, Raijmakers RP, Bleeker-Rovers CP, van der Meer JW, Netea MG, Schoffelen T, van Deuren M. Altered interferon-γ response in patients with Q-fever fatigue syndrome. J Infect. 2016 Apr;72(4):478-85. doi: 10.1016/j.jinf.2016.01.004.

  • Keijmel SP, Delsing CE, Bleijenberg G, van der Meer JWM, Donders RT, Leclercq M, Kampschreur LM, van den Berg M, Sprong T, Nabuurs-Franssen MH, Knoop H, Bleeker-Rovers CP. Effectiveness of Long-term Doxycycline Treatment and Cognitive-Behavioral Therapy on Fatigue Severity in Patients with Q Fever Fatigue Syndrome (Qure Study): A Randomized Controlled Trial. Clin Infect Dis. 2017 Apr 15;64(8):998-1005. doi: 10.1093/cid/cix013. 

  • König BH, van Jaarsveld CH, Bischoff EW, Schers HJ, Lucassen PL, Olde Hartman TC. Prognostic factors for persistent fatigue after COVID-19: a prospective matched cohort study in primary care. Br J Gen Pract. 2023 Apr 27;73(730):e340-e347. doi: 10.3399/BJGP.2022.0158.

  • Kuut TA, Müller F, Csorba I, Braamse A, Aldenkamp A, Appelman B, Assmann-Schuilwerve E, Geerlings SE, Gibney KB, Kanaan RAA, Mooij-Kalverda K, Hartman TCO, Pauëlsen D, Prins M, Slieker K, van Vugt M, Keijmel SP, Nieuwkerk P, Rovers CP, Knoop H. Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clin Infect Dis. 2023 Sep 11;77(5):687-695. doi: 10.1093/cid/ciad257. 

  • Kuut TA, Müller F, Csorba I, Braamse AMJ, Nieuwkerk P, Rovers CP, Knoop H. Positive Effects of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following COVID-19 Are Sustained Up to 1 Year After Treatment. Clin Infect Dis. 2024 Apr 10;78(4):1078-1079. doi: 10.1093/cid/ciad661.

  • Li H, Cvejic E, Gu B, Vollmer-Conna U, Hickie I, Wakefield D, Davenport T, Wiley J, Lloyd AR. Regulation of the acute sickness response by the P2RX7 receptor. J Infect Dis. 2021 Sep 1;224(5):914-920. doi: 10.1093/infdis/jiab027.

  • Raijmakers RPH, Jansen AFM, Keijmel SP, Ter Horst R, Roerink ME, Novakovic B, Joosten LAB, van der Meer JWM, Netea MG, Bleeker-Rovers CP. A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome. J Transl Med. 2019 May 14;17(1):157. doi: 10.1186/s12967-019-1906-3. 

  • Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, Knoop H, Klein H, Bleeker-Rovers C, Doorduin J. No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [11C]-PK11195. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 23;9(1):e1113. doi: 10.1212/NXI.0000000000001113. 

  • Raijmakers RPH, Roerink ME, Jansen AFM, Keijmel SP, Gacesa R, Li Y, Joosten LAB, van der Meer JWM, Netea MG, Bleeker-Rovers CP, Xu CJ. Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome. J Transl Med. 2020 Nov 26;18(1):448. doi: 10.1186/s12967-020-02585-5. 

  • Raijmakers RPH, Koeken VACM, Jansen AFM, Keijmel SP, Roerink ME, Joosten LAB, Netea MG, van der Meer JWM, Bleeker-Rovers CP. Cytokine profiles in patients with Q fever fatigue syndrome. J Infect. 2019 May;78(5):349-357. doi: 10.1016/j.jinf.2019.01.006.

  • Rea T, Russo J, Katon W, Ashley RL, Buchwald D. A prospective study of tender points and fibromyalgia during and after an acute viral infection. Arch Intern Med. 1999 Apr 26;159(8):865-70. doi: 10.1001/archinte.159.8.865.

  • Rea TD, Russo JE, Katon W, Ashley RL, Buchwald DS. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract. 2001 Jul-Aug;14(4):234-42. PMID: 11458965.

  • Rea TD, Ashley RL, Russo JE, Buchwald DS. A systematic study of Epstein-Barr virus serologic assays following acute infection. Am J Clin Pathol. 2002 Jan;117(1):156-61. doi: 10.1309/ETK2-L9MG-L6RA-N79Y.

  • Reukers DFM, van Jaarsveld CHM, Akkermans RP, Keijmel SP, Morroy G, van Dam ASG, Wever PC, Wielders CCH, van der Velden K, van Loenhout JAF, Hautvast JLA. Impact of Q-fever on physical and psychosocial functioning until 8 years after Coxiella burnetii infection: An integrative data analysis. PLoS One. 2022 Feb 2;17(2):e0263239. doi: 10.1371/journal.pone.0263239. 

  • Reukers DFM, van Jaarsveld CHM, Knoop H, Bleeker-Rovers CP, Akkermans R, de Grauw W, van der Velden K, van Loenhout JAF, Hautvast JLA. Explaining the long-term impact of chronic Q fever and Q fever fatigue syndrome on psychosocial functioning: A comparison with diabetes and the general population. J Psychosom Res. 2019 Jun;121:37-45. doi: 10.1016/j.jpsychores.2019.03.185.

  • Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Prevalence and Determinants of Fatigue after COVID-19 in Non-Hospitalized Subjects: A Population-Based Study. Int J Environ Res Public Health. 2021 Feb 19;18(4):2030. doi: 10.3390/ijerph18042030. 

  • Stavem K, Einvik G, Tholin B, Ghanima W, Hessen E, Lundqvist C. Cognitive function in non-hospitalized patients 8-13 months after acute COVID-19 infection: A cohort study in Norway. PLoS One. 2022 Aug 22;17(8):e0273352. doi: 10.1371/journal.pone.0273352.

  • Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021 Apr;76(4):405-407. doi: 10.1136/thoraxjnl-2020-216377. 

  • Ursinus, J., H. D. Vrijmoeth, M. G. Harms, A. D. Tulen, H. Knoop, S. A. Gauw, T. P. Zomer, A. Wong, I. H. M. Friesema, Y. M. Vermeeren, L. A. B. Joosten, J. W. Hovius, B. J. Kullberg, and C. C. van den Wijngaard. "Prevalence of Persistent Symptoms after Treatment for Lyme Borreliosis: A Prospective Observational Cohort Study." Lancet Reg Health Eur 6 (Jul 2021): 100142. doi: 10.1016/j.lanepe.2021.100142.

  • Van der Maaden, T., E. N. Mutubuki, S. de Bruijn, K. Y. Leung, H. Knoop, J. Slootweg, A. D. Tulen, A. Wong, A. J. van Hoek, E. Franz, and C. C. van den Wijngaard. "Prevalence and Severity of Symptoms 3 Months after Infection with Sars-Cov-2 Compared to Test-Negative and Population Controls in the Netherlands." J Infect Dis 227, no. 9 (Apr 26 2023): 1059-67. doi: 10.1093/infdis/jiac474.

  • Van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022 Jan 19;39(1):159-167. doi: 10.1093/fampra/cmab076. 

  • Verveen A, Wynberg E, van Willigen HDG, Davidovich U, Lok A, Moll van Charante EP, de Jong MD, de Bree G, Prins M, Knoop H, Nieuwkerk PT; RECoVERED Study Group. Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort study. BMC Med. 2022 Nov 2;20(1):422. doi: 10.1186/s12916-022-02615-7. 

  • Vrijmoeth, H. D., J. Ursinus, J. Botey-Bataller, Y. Kuijpers, X. Chu, F. R. van de Schoor, B. P. Scicluna, C. J. Xu, M. G. Netea, B. J. Kullberg, C. C. van den Wijngaard, Y. Li, J. W. Hovius, and L. A. B. Joosten. "Genome-Wide Analyses in Lyme Borreliosis: Identification of a Genetic Variant Associated with Disease Susceptibility and Its Immunological Implications." BMC Infect Dis 24, no. 1 (Mar 21 2024): 337. doi: 10.1186/s12879-024-09217-z.

  • Vrijmoeth, H. D., J. Ursinus, M. G. Harms, A. D. Tulen, M. E. Baarsma, F. R. van de Schoor, S. A. Gauw, T. P. Zomer, Y. M. Vermeeren, J. A. Ferreira, H. Sprong, K. Kremer, H. Knoop, L. A. B. Joosten, B. J. Kullberg, J. W. Hovius, and C. C. van den Wijngaard. "Determinants of Persistent Symptoms after Treatment for Lyme Borreliosis: A Prospective Observational Cohort Study." EBioMedicine 98 (Dec 2023): 104825. doi: 10.1016/j.ebiom.2023.104825.

  • Wagner HJ, Scott RS, Buchwald D, Sixbey JW. Peripheral blood lymphocytes express recombination-activating genes 1 and 2 during Epstein-Barr virus-induced infectious mononucleosis. J Infect Dis. 2004 Sep 1;190(5):979-84. doi: 10.1086/423211. 

bottom of page